New drug shows promise for muscle disease in small trial
Disease control
Completed
This study tested a drug called vamorolone in 46 males with Becker muscular dystrophy, a condition that causes muscle weakness. Participants took either the drug or a placebo daily for 24 weeks. The main goal was to check safety and side effects, and to see if the drug might help…
Phase: PHASE2 • Sponsor: ReveraGen BioPharma, Inc. • Aim: Disease control
Last updated May 14, 2026 12:05 UTC